Article
Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Oct 2014
Lin Jung-An, Chen Yeu-Chin, Cheng Shin-Nan, Chen Peng-Jen, Chu Heng-Cheng, Hsieh Tsai-Yuan, Shih Yu-Lueng
Abstract excerpt
BACKGROUND/PURPOSE: Chronic hepatitis C virus (HCV) infection is a major cause of morbidity and mortality in patients with hemophilia. However, the efficacy and safety of pegylated interferon (PEG-IFN) plus ribavirin (RBV) for hemophilic patients with chronic HCV infection in Taiwan are still unknown. The aim of this study is to report the efficacy and safety of PEG-IFN plus RBV in a single center in Taiwan....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
